scisparc.com - שווי חברה להכנסות SPRC

The absence of commercial revenue due to the clinical testing stage has created a high dependence on investments, which confirms the business valuation relative to revenue for SciSparc Ltd (SPRC). The value 9073.53 reflects the most recent metric value. Meanwhile, steady demand for autism therapy isolates the company from macroeconomic trends, while a strong neuroscience team ensures the preservation of key scientific competencies.
SciSparc Ltd. - פילוחים אנליטיים ומדדי מפתח (SPRC)

SciSparc Ltd (SPRC) potential for monopoly dominance in CNS therapy lays the foundation for a high market premium, which this ratio reflects. The metric compares the total enterprise value (equity plus net debt) to sales volume, eliminating the impact of leverage on the fundamental valuation. A sharp deviation of the enterprise value-to-revenue ratio from industry norms warns of an overheated asset and the risk of a correction should revenue growth rates slow.